In spite of the prospect of a protracted regulatory review and AVGO's previous run-ins with US and European regulators, we don't expect its pursuit of VWM to suffer the same fate as the NVDA/Arm deal.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.